Endocrinology

>

The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.

Latest News

Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center
Oral Semaglutide Reduces MACE Risk in People With Type 2 Diabetes and CVD

October 21st 2024

Novo Nordisk will present more detailed data in 2025 and plans to file for an expanded label for Rybelsus for this population.

US FDA LOGO IN BLACK OVER A WHITE BACKGROUND. | Credit: US Food and Drug Administration
FDA Issues Second CRL for Dasiglucagon (Zegalogue) in Congenital Hyperinsulinism

October 8th 2024

Pam Taub, MD | Credit: UC San Diego Health
Time-Restricted Eating Shows Promise for Metabolic Syndrome in 3-Month Trial

October 8th 2024

HCPLive Endocrinology Month in Review September 2024 thumbnail
Endocrinology Month in Review: September 2024

October 6th 2024

FDA Decisions to Watch in Q4 2024 thumbnail
5 FDA Decisions to Watch in Q4 2024

October 4th 2024

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP

Thumbnail logo for Diabetes Dialogue podcast
Latest CME Events & Activities
<1
...
145146147148149
© 2024 MJH Life Sciences

All rights reserved.